Department of Medicine, Division of Pulmonary and Critical Care Medicine, Keck School of Medicine of USC, 2020 Zonal Avenue, IRD Room 723, Los Angeles, CA 90033, USA.
Clin Chest Med. 2011 Dec;32(4):749-62. doi: 10.1016/j.ccm.2011.08.012.
This article discusses the potential benefits and limitations of positron emission tomography (PET) for characterizing lung nodules, staging the mediastinum, identifying occult distant metastasis, determining prognosis and treatment response, guiding plans for radiation therapy, restaging during and after treatment, and selecting targets for tissue sampling. The key findings from the medical literature are presented regarding the capabilities and fallibilities of PET in lung cancer evaluation, including characterization of pulmonary nodules and staging in patients with known or suspected non-small-cell lung cancer. The discussion is limited to PET imaging with fluorodeoxyglucose.
本文讨论了正电子发射断层扫描（PET）在肺结节特征描述、纵隔分期、隐匿性远处转移的识别、预后和治疗反应判断、放射治疗计划指导、治疗期间和治疗后的再分期以及组织取样靶点选择方面的潜在优势和局限性。重点介绍了关于氟脱氧葡萄糖 PET 在肺癌评估中的作用和局限性的医学文献中的关键发现，包括对已知或疑似非小细胞肺癌患者肺结节的特征描述和分期。讨论仅限于氟脱氧葡萄糖 PET 成像。
